文献速递妇科

卵巢癌患者中四种简短抑郁筛查工具的比较:传统与替代临界值的诊断准确性

Comparison of four brief depression screening instruments in ovarian cancer patients: Diagnostic accuracy using traditional versus alternative cutpoints.
PubMed 文献 · Gynecol Oncol · 2017-04-08

在153例接受化疗的卵巢癌患者中比较CES-D、BDI-FastScreen、PHQ-9和单条目筛查问卷对重性抑郁发作(MDE)的诊断准确性。以SCID-DSM IV为金标准,仅14例(9%)符合当前MDE。PHQ-9两阶段评分法采用替代临界值6时阳性预测值最高(PPV=32%),CES-D传统临界值16时PPV最低(5%)。

要点

  • 153例卵巢癌患者中仅14例(9%)符合SCID-DSM IV当前MDE标准。
  • PHQ-9两阶段评分法采用替代临界值6时PPV最高(32%)。
  • CES-D临界值16时PPV最低(5%),临界值22时PPV为7%。

核心结论

  • PHQ-9两阶段筛查总体表现最佳,在未接受抗抑郁药治疗的患者中准确性有所提高。

研究设计与样本

  • 在新化疗方案开始时,卵巢癌患者同日完成CES-D、BDI-FastScreen、PHQ-9和单条目筛查问卷(「你抑郁吗?」)。
  • 以SCID-DSM IV重性抑郁发作(MDE)为金标准,计算各工具的敏感度、特异度、阳性预测值和阴性预测值。
  • 为控制抗抑郁药使用的影响,在未服用抗抑郁药的患者亚组中重新进行分析。
  • 共153例卵巢癌患者入组。

主要发现

  • 仅14例(9%)符合SCID当前MDE标准。
  • 在全部患者中(不论是否已接受抗抑郁药治疗),PHQ-9两阶段评分法采用替代临界值6时阳性预测值最高(PPV=32%)。
  • CES-D传统临界值16时PPV最低(5%);采用更严格的临界值22时PPV略有改善但仍较差,为7%。

关键数值与推荐

  • PHQ-9两阶段评分法替代临界值6:PPV=32%(全部患者)。
  • CES-D传统临界值16:PPV=5%;临界值22:PPV=7%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We compared the diagnostic accuracy of 4 depression screening scales, using traditional and alternative scoring methods, to the gold standard Structured Clinical Interview-DSM IV major depressive episode (MDE) in ovarian cancer patients on active treatment. METHODS: At the beginning of a new chemotherapy regimen, ovarian cancer patients completed the following surveys on the same day: the Center for Epidemiological Studies Depression Scale (CES-D), the Beck Depression Inventory Fast-Screen for Primary Care (BDI-FastScreen), the Patient Health Questionnaire-9 (PHQ-9), and a 1-item screener ("Are you depressed?"). Each instrument's sensitivity, specificity, positive predictive value (PPV) and negative predictive value were calculated with respect to major depression. To control for antidepressant use, the analyses were re-run for a subsample of patients who were not on antidepressants. RESULTS: One hundred fifty-three ovarian cancer patients were enrolled into the study. Only fourteen participants met SCID criteria for current MDE (9%). When evaluating all patients regardless of whether they were already being treated with antidepressants, the two-phase scoring approach with an alternate cutpoint of 6 on the PHQ-9 had the best positive predictive value (PPV=32%). Using a traditional cutpoint of 16 on the CES-D resulted in the lowest PPV (5%); using a more stringent cutpoint of 22 resulted in a slightly improved but still poor PPV, 7%. CONCLUSIONS: Screening with a two-phase PHQ-9 proved best overall, and its accuracy was improved when used with patients who were not already being treated with antidepressants.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Shinn EH, Valentine A, Baum G, et al. Comparison of four brief depression screening instruments in ovarian cancer patients: Diagnostic accuracy using traditional versus alternative cutpoints. Gynecol Oncol. 2017. PMID: 28400146. doi:10.1016/j.ygyno.2017.03.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。